These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
323 related articles for article (PubMed ID: 18281756)
1. [Genomic markers and anticancer chemotherapy]. Nishiyama M Gan To Kagaku Ryoho; 2008 Feb; 35(2):194-9. PubMed ID: 18281756 [TBL] [Abstract][Full Text] [Related]
2. [Polygenetic pharmacogenomic strategies to identify drug sensitivity biomarkers]. Nishiyama M Gan To Kagaku Ryoho; 2005 Nov; 32(12):1902-7. PubMed ID: 16282724 [TBL] [Abstract][Full Text] [Related]
3. [Genome research and anticancer chemotherapy]. Hayashi I; Nishiyama M Gan To Kagaku Ryoho; 2001 Sep; 28(9):1183-9. PubMed ID: 11579627 [TBL] [Abstract][Full Text] [Related]
4. Molecular prediction of the therapeutic response to neoadjuvant chemotherapy in breast cancer. Nagasaki K; Miki Y Breast Cancer; 2008; 15(2):117-20. PubMed ID: 18274834 [TBL] [Abstract][Full Text] [Related]
5. [Pharmacogenetics of anticancer drugs]. de Chaisemartin L; Loriot MA Pathol Biol (Paris); 2005 Mar; 53(2):116-24. PubMed ID: 15708657 [TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics for individualized cancer chemotherapy. Efferth T; Volm M Pharmacol Ther; 2005 Aug; 107(2):155-76. PubMed ID: 15890408 [TBL] [Abstract][Full Text] [Related]
8. [Current status and problems of tailor-made medicine in anticancer therapy]. Miya T Gan To Kagaku Ryoho; 2007 Apr; 34(4):515-9. PubMed ID: 17431334 [TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomics in breast cancer: current trends and future directions. Wajapeyee N; Somasundaram K Curr Opin Mol Ther; 2004 Jun; 6(3):296-301. PubMed ID: 15264432 [TBL] [Abstract][Full Text] [Related]
10. Genomic strategies for personalized cancer therapy. Garman KS; Nevins JR; Potti A Hum Mol Genet; 2007 Oct; 16 Spec No. 2():R226-32. PubMed ID: 17911165 [TBL] [Abstract][Full Text] [Related]
11. Personalized cancer therapy with selective kinase inhibitors: an emerging paradigm in medical oncology. McDermott U; Settleman J J Clin Oncol; 2009 Nov; 27(33):5650-9. PubMed ID: 19858389 [TBL] [Abstract][Full Text] [Related]
12. Gene expression profiles as biomarkers for the prediction of chemotherapy drug response in human tumour cells. Parissenti AM; Hembruff SL; Villeneuve DJ; Veitch Z; Guo B; Eng J Anticancer Drugs; 2007 Jun; 18(5):499-523. PubMed ID: 17414620 [TBL] [Abstract][Full Text] [Related]
13. [Anticancer drug dosing--pharmacogenomic biomarkers or body surface area?]. Lehne G; Bjørheim J; Saeter G Tidsskr Nor Laegeforen; 2007 Apr; 127(8):1040-4. PubMed ID: 17457389 [TBL] [Abstract][Full Text] [Related]
15. Predicting cancer drug response by proteomic profiling. Ma Y; Ding Z; Qian Y; Shi X; Castranova V; Harner EJ; Guo L Clin Cancer Res; 2006 Aug; 12(15):4583-9. PubMed ID: 16899605 [TBL] [Abstract][Full Text] [Related]
16. Predicting drug response based on gene expression. Robert J; Vekris A; Pourquier P; Bonnet J Crit Rev Oncol Hematol; 2004 Sep; 51(3):205-27. PubMed ID: 15331079 [TBL] [Abstract][Full Text] [Related]
17. Somatic pharmacogenomics in cancer. Ikediobi ON Pharmacogenomics J; 2008 Oct; 8(5):305-14. PubMed ID: 18679398 [TBL] [Abstract][Full Text] [Related]
18. Applications of genomic tools to colorectal cancer therapeutics. Auman JT; McLeod HL Curr Opin Mol Ther; 2008 Dec; 10(6):548-54. PubMed ID: 19051132 [TBL] [Abstract][Full Text] [Related]
19. Genetic tests for predicting the toxicity and efficacy of anticancer chemotherapy. Mladosievicova B; Carter A; Kristova V Neoplasma; 2007; 54(3):181-8. PubMed ID: 17447847 [TBL] [Abstract][Full Text] [Related]
20. Gene expression-based diagnosis of efficacy of chemotherapy for breast cancer. Miki Y Breast Cancer; 2010 Apr; 17(2):97-102. PubMed ID: 20013078 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]